β-Mangostin inhibits the metastatic power of cervical cancer cells attributing to suppression of JNK2/AP-1/Snail cascade.
Chun-Shiang LinChia-Liang LinTsung-Ho YingHui-Ling ChiouChia-Hung HungWei-Shan LiaoYi-Hsien HsiehShao-Hsuan KaoPublished in: Journal of cellular physiology (2020)
β-Mangostin is a natural mangostin with potent anticancer activity against various cancers. In this study, we further explored the anticancer activity of β-mangostin on cervical cancer cells. β-Mangostin did not affect cell viability and cell cycle distribution in HeLa and SiHa cells; however, it dose-dependently inhibited the migration and invasion of both the human cervical cancer cell lines. In addition, we observed that β-mangostin suppressed the expression of integrin αV and β3 and the downstream focal adhesion kinase/Src signaling. We also found that Snail was involved in the β-mangostin inhibited cell migration and invasion of HeLa cell. Then, our findings showed that β-mangostin reduced both nuclear translocation and messenger RNA expression of AP-1 and demonstrated that AP-1 could target to the Snail promoter and induce Snail expression. Kinase cascade analysis and reporter assay showed that JNK2 was involved in the inhibition of AP-1/Snail axis by β-mangostin in HeLa cells. These results indicate that β-mangostin can inhibit the mobility and invasiveness of cervical cancer cells, which may attribute to the suppression of both integrin/Src signaling and JNK2-mediated AP-1/Snail axis. This suggests that β-mangostin has potential antimetastatic potential against cervical cancer cells.
Keyphrases
- epithelial mesenchymal transition
- induced apoptosis
- transcription factor
- cell cycle arrest
- cell cycle
- poor prognosis
- cell death
- signaling pathway
- tyrosine kinase
- endothelial cells
- cell proliferation
- squamous cell carcinoma
- oxidative stress
- cell therapy
- stem cells
- escherichia coli
- binding protein
- pluripotent stem cells